Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Int. braz. j. urol ; 39(6): 867-874, Nov-Dec/2013. tab, graf
Article in English | LILACS | ID: lil-699120

ABSTRACT

Purpose To assess the prevalence of LUTS, urinary tract and urodynamics changes in patients with Friedreich's Ataxia (FA), the most common form of hereditary ataxia. Materials and Methods This study evaluated 258 patients with genetically confirmed diagnoses of FA. Of the patients, 158 responded to a questionnaire which assessed their urinary symptoms. Patients with clinical changes underwent renal function examinations, ultrasound, and urodynamic studies (UDS). Results The sample analyzed showed that 82% of the patients complained of LUTS, although only 22% related the symptoms with quality of life impairment. Twenty eight (18%) of them agreed to undergo urodynamic evaluation. Urgency was the most common symptom. The exam was normal in 4 (14%) and detrusor underactivity was the most common finding. 14% (4 patients) presented with dilatation of the upper urinary tract at ultrasound scans. None of them had creatinine alterations. Conclusions LUTS was found in a large percentage of patients with FA, but only a few related it to their quality of life impairment. Although creatinine levels was normal in this sample, some patients may show upper urinary tract abnormalities, with deserves close observation and proper care. .


Subject(s)
Adult , Female , Humans , Male , Young Adult , Friedreich Ataxia/physiopathology , Lower Urinary Tract Symptoms/physiopathology , Urinary Bladder/physiopathology , Urodynamics/physiology , Brazil/epidemiology , Lower Urinary Tract Symptoms/epidemiology , Prevalence , Sex Factors , Surveys and Questionnaires , Time Factors , Urination Disorders/physiopathology
2.
Int. braz. j. urol ; 36(6): 732-737, Dec. 2010. tab
Article in English | LILACS | ID: lil-572402

ABSTRACT

PURPOSE: To evaluate the efficacy of botulinum toxin type A injections in the detrusor muscle in patients with spinal cord injury and urinary incontinence due to detrusor overactivity and refractory to anticholinergic agents. MATERIALS AND METHODS: We prospectively evaluated 22 patients with spinal cord injuries, whose bladders were emptied by intermittent catheterization. All patients had detrusor overactivity and urinary incontinence that proved difficult to treat, despite using high doses of two different anticholinergics. The pre-treatment assessment included a complete urodynamic study and ultrasonography of the kidneys and urinary tract. A one-month follow-up was completed with urodynamic evaluation and the clinical response was evaluated through outpatient consultations and telephone contact. RESULTS: After the procedure, the maximum cystometric capacity and the bladder reflex volume increased, whereas the maximum detrusor pressure and compliance decreased. The mean duration of continence was 7 ± 7 months. In 18 patients (81.8 percent), it was necessary to administer anticholinergics to achieve continence. Five patients (22.7 percent) had indication of reinjection, and augmentation cystoplasty was indicated in 9 patients (40.9 percent). CONCLUSION: The use of botulinum toxin in the treatment of neurogenic detrusor overactivity refractory to anticholinergics is an option before more invasive treatments, such as augmentation cystoplasty, are attempted. In our study as well as in the literature, there was improvement in most urodynamic parameters. Overall, 40.9 percent of patients underwent augmentation cystoplasty and 81.8 percent of patients needed anticholinergic agents to reach urinary continence. Further studies are necessary to improve the procedure and to achieve better clinical results.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Botulinum Toxins, Type A/therapeutic use , Cholinergic Antagonists/therapeutic use , Neuromuscular Agents/therapeutic use , Spinal Cord Injuries/complications , Urinary Bladder, Overactive/drug therapy , Urinary Incontinence/drug therapy , Follow-Up Studies , Injections, Intramuscular , Time Factors , Treatment Outcome , Urinary Bladder, Neurogenic/drug therapy
3.
J. bras. neurocir ; 21(3): 175-178, 2010.
Article in English | LILACS | ID: lil-579604

ABSTRACT

Introdução: O Cisto ósseo aneurismático é uma lesão óssea benigna e destrutiva de origem desconhecida. Os tratamentos atuais para esta doença incluem a ressecção em bloco, curetagem,embolização arterial seletiva e radioterapia. Um caso de cisto ósseo aneurismático gigante da coluna lombar é relatado.Método: Paciente de 15 anos de idade foi admitido com dor lombar e paraparesia com três meses de duração. Os exames radiológicos demonstraram uma lesão lítica expansiva nos processos espinhosos e lâminas da quarta e quinta vértebras lombares. A cirurgia consistiu da ressecção e instrumentação posterior com fusão de L2 até S1. A histopatologia demonstrou um cisto ósseo aneurismático. Após um ano de pós-operatório,o paciente melhorou a sua função neurológica, permanecendo apenas com uma paresia de L5 bilateral. Discussão: O tratamento do cisto ósseo aneurismático é desafiante, principalmente se próximo a estruturas neurais e vasculares. A fusão óssea e estabilização com instrumentação são frequentemente necessárias após a ressecção radical de tumores vertebrais extensos. Uma vértebra geralmente é acometida pelos cistos ósseos e lesões extensas são incomuns. A ressecção completado tumor e a fusão da coluna lombar com instrumentação permitiram a cura com preservação da estabilidade espinhal. As complicações neurológicas podem ser melhoradas com a retirada cirúrgica do tumor.


Subject(s)
Adolescent , Bone Cysts, Aneurysmal , General Surgery , Spine
5.
s.l; MedWriters; 2010. 112 p. ilus, tab.
Monography in Portuguese | LILACS, AHM-Acervo, TATUAPE-Acervo | ID: lil-713331
SELECTION OF CITATIONS
SEARCH DETAIL